September 21, 2014 5:41 PM ET

Biotechnology

Company Overview of Chroma Therapeutics Ltd.

Executive Profile

Anthony Kouzarides Ph.D.

Founder and Member of Scientific Advisory Board, Chroma Therapeutics Ltd.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
56--

Background

Dr. Anthony Kouzarides, Ph.D., known as Tony serves as Professor of Royal Society Napier at University of Cambridge. From 1986 to 1989, Prof. Kouzarides spent three years working as a research fellow in the laboratory of Professor Ed Ziff at New York University Medical Center, where he discovered a fundamental principle underlying the association of proteins involved in human cancer. He co-founded Abcam Plc in 1998. Prof. Kouzarides founded Chroma Therapeutics Ltd. (Chromatin ...

Corporate Headquarters

93 Innovation Drive
Abingdon, Oxfordshire OX14 4RY

United Kingdom

Phone: 44 1235 829120
Fax: 44 1235 829125

Board Members Memberships

1998-2012
Co-Founder

Education

PhD
University of Cambridge
BS
University of Leeds

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chroma Therapeutics Ltd., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.